Skip to main content
Start of content
Top of Page

M-40 Drug and vaccine manufacturing

44th Parliament, 1st Session

Motion Text

That, in the opinion of the House, the government should establish: (a) a federal Crown corporation to manufacture essential, affordable medicines and vaccines in Canada; and (b) a funding mechanism to develop clinical trial research capacity and infrastructure for supporting end-to-end biomedical research and development of new drugs and vaccines discovered in Canadian universities and other research institutes, including the provision of the necessary venture capital to ensure the viability of this initiative.


Latest Activity

December 1, 2021
Placed on Notice

History

December 1, 2021
Placed on Notice